171 related articles for article (PubMed ID: 32310720)
21. Addressing High Drug Prices by Reforming Pharmacy Benefit Managers.
Rome BN
J Law Med Ethics; 2023; 51(S2):46-51. PubMed ID: 38433673
[TBL] [Abstract][Full Text] [Related]
22. Pharmaceuticals: Pharmacy Benefit Managers (PBMs).
Seay M; Lee LL
Issue Brief Health Policy Track Serv; 2007 Jan; ():1-14. PubMed ID: 17361468
[No Abstract] [Full Text] [Related]
23. The impact of pharmacy benefit managers on community pharmacy: A scoping review.
Rosenthal M; Miller L; Bateman M; Smith M; Nueva K; Ballou JM
Explor Res Clin Soc Pharm; 2023 Jun; 10():100283. PubMed ID: 37333968
[TBL] [Abstract][Full Text] [Related]
24. Rebates and spreads: pharmacy benefit management practices and corporate citizenship.
Rentmeester CA; Garis RI
J Health Polit Policy Law; 2008 Oct; 33(5):943-63; discussion 965-978. PubMed ID: 18818428
[TBL] [Abstract][Full Text] [Related]
25. Accounting principles, revenue recognition, and the profitability of pharmacy benefit managers.
McLean RA; Garis RI
Res Social Adm Pharm; 2005 Mar; 1(1):118-25. PubMed ID: 17138469
[TBL] [Abstract][Full Text] [Related]
26. The spotlight on PBMs: federal enforcement of the anti-kickback statute on the pharmaceutical benefit management industry.
Radinsky G
J Health Law; 2003; 36(2):213-46. PubMed ID: 12940677
[TBL] [Abstract][Full Text] [Related]
27. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand.
Hansen RA; Roth MT; Brouwer ES; Herndon S; Christensen DB
J Am Pharm Assoc (2003); 2006; 46(6):700-6. PubMed ID: 17176685
[TBL] [Abstract][Full Text] [Related]
28. Wrangling prescription drug benefits: a conversation with Express Scripts' Barrett Toan. Interview by Robert F. Atlas.
Toan B
Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-191-W5-198. PubMed ID: 15840628
[TBL] [Abstract][Full Text] [Related]
29. Working with PBMs (pharmacy benefit managers).
Peterson C
Healthplan; 1999; 40(2):83-6, 88-9. PubMed ID: 10537477
[No Abstract] [Full Text] [Related]
30. Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions.
Grabowski H; Mullins CD
Soc Sci Med; 1997 Aug; 45(4):535-44. PubMed ID: 9226779
[TBL] [Abstract][Full Text] [Related]
31. Pharmacy benefit managers: a model for Medicare?
Goff VV
Issue Brief Natl Health Policy Forum; 2001 Jul; (765):1-12. PubMed ID: 11699507
[TBL] [Abstract][Full Text] [Related]
32. Factors influencing the delivery of pharmacy services.
Miller MJ; Ortmeier BG
Am Pharm; 1995 Jan; NS35(1):39-45. PubMed ID: 7887373
[TBL] [Abstract][Full Text] [Related]
33. Developing an effective generic prescription drug program.
Jones JD
Benefits Q; 2003; 19(1):14-8. PubMed ID: 12608114
[TBL] [Abstract][Full Text] [Related]
34. "If one PBM won't give it to them, they'll get it from another PBM".
Merritt M
Mod Healthc; 2016 Oct; 46(40):28-29. PubMed ID: 30399234
[TBL] [Abstract][Full Text] [Related]
35. Financial Impact of Medically Integrated Pharmacy Interventions on Oral Oncolytic Prescriptions.
Darling JO; Starkey AJ; Nubla JJ; Reff MJ
JCO Oncol Pract; 2022 Jul; 18(7):e1225-e1230. PubMed ID: 35561289
[TBL] [Abstract][Full Text] [Related]
36. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
[TBL] [Abstract][Full Text] [Related]
37. The Daniel K. Inouye College of Pharmacy Scripts: Prescription Drug Pricing.
Sumida WK; Taniguchi R; Juarez DT
Hawaii J Med Public Health; 2016 Jan; 75(1):25-30. PubMed ID: 26870605
[TBL] [Abstract][Full Text] [Related]
38. Pharmaceutical care in community pharmacies: practice and research in the US.
Christensen DB; Farris KB
Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
[TBL] [Abstract][Full Text] [Related]
39. A blueprint for pharmacy benefit managers to increase value.
Shrank WH; Porter ME; Jain SH; Choudhry NK
Am J Manag Care; 2009 Feb; 15(2):87-93. PubMed ID: 19284805
[TBL] [Abstract][Full Text] [Related]
40. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
Wright-De Agüero L; Weinstein B; Jones TS; Miles J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
